Maternal bronchodilator use and the risk of orofacial clefts

Human Reproduction

Volumn 26, Issue 11, 2011, Pages 3147-3154

  Munsie, Jeanpierre W ^a   Lin, Shao ^a,b   Browne, Marilyn L ^a,b   Campbell, Kimberly A ^a   Caton, Alissa R ^a,b   Bell, Erin M ^b   Rasmussen, Sonja A ^c   Romitti, Paul A ^d   Druschel, Charlotte M ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b UNIVERSITY AT ALBANY   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

asthma; birth defects; bronchodilator agents; orofacial clefts

Indexed keywords

ADRENALIN; BECLOMETASONE; BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; EPHEDRINE; FLUNISOLIDE; FLUTICASONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; METHYLPREDNISOLONE; MONTELUKAST; ORCIPRENALINE; PIRBUTEROL; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; BIRTH DEFECT; CHILDBIRTH; CLEFT LIP PALATE; CLEFT PALATE; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSOSTOSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; MULTICENTER STUDY; POPULATION BASED CASE CONTROL STUDY; RISK;

EID: 80054882021     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der315     Document Type: Article

References (44)

1. Abrishamchian AR, Khoury MJ, Calle EE. The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: a population based case-control study. Genet Epidemiol 1994;11:343-351. (Pubitemid 24313595)
2. Beaty TH, Hetmanski JB, Fallin MD, Park JW, Sull JW, McIntosh I, Liang KY, Vanderkolk CA, Redett RJ, Boyadjiev SA et al. Analysis of candidate genes on Chromosome 2 in oral cleft case-parent trios from three populations. Hum Genet 2009;126:385-394.
3. Bille C, Olsen J, Vach W, Knudsen VK, Olsen F, Rasmussen K, Murray JC, Kristensen K. Oral cleft and life style factors-a case-cohort study based on prospective Danish data. Eur J Epidemiol 2007;22:173-181. (Pubitemid 46481326)
4. Blais L, Kettani FZ, Elftouh N, Forget A. Effect of maternal asthma on the risk of specific congenital malformations: a population-based cohort study. Birth Defects Res A Clin Mol Teratol 2010;88:216-222.
5. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, the National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007;197:585.e1-585.e7.
6. Carter TC, Molloy AM, Pangilinan F, Troendle JF, Kirke PN, Conley MR, Orr DJ, Earley M, McKiernan E, Lynn EC et al. Testing reported associations of genetic risk factors for oral clefts in a large Irish study population. J Dent Res 2009;88:715-718.
7. Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects-United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006; 54:1301-1305.
8. Chambers K. Asthma education and outcomes for women of childbearing age. Case Manager 2003;14:58-61. (Pubitemid 37421147)
9. Chevrier C, Dananché B, Bahuau M, Nelva A, Herman C, Francanet C, Robert-Gnansia E, Cordier S. Occupational exposure to organic solvent mixtures during pregnancy and the risk of non-syndromic oral clefts. Occup Environ Med 2006;63:617-623. (Pubitemid 44358613)
10. Croen LA, Shaw GM, Wasserman CR, Tolarova MM. Racial and ethnic variations in the prevalence of orofacial clefts in California 1983-1992. Am J Med Genet 1998;79:42-47. (Pubitemid 28402418)
11. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56: 335-340. (Pubitemid 28035180)
12. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998; 158:1091-1095. (Pubitemid 28489006)
13. Dravet C, Julian C, Legras C, Magaudda A, Guerrini R, Genton P, Soulayrol S, Giraud N, Mesdjian E, Trentin G. Epilepsie, antiepileptic drugs, and malformations in children of women with epilepsie: a French prospective cohort study. Neurology 1992;42(suppl.5):75-82.
14. Forrester MB, Merz RD. Descriptive epidemiology of oral clefts in a multiethnic population, Hawaii, 1986-2000. Cleft Palate Craniofac J 2004;41:622-628. (Pubitemid 39506895)
15. Gordon JE, Shy CM. Agricultural chemical use and congenital cleft lip and/or palate. Arch Environ Health 1981;36:213-221. (Pubitemid 11026819)
16. Green RF, Devine O, Crider KS, Olney RS, Archer N, Olshan AF, Shapira SK. National Birth Defects Prevention Study Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol 2010;20:241-249.
17. Harville EW, Wilcox AJ, Lie RT, Abyholm F, Vindenes H. Epidemiology of cleft palate alone and cleft palate with accompanying defects. Eur J Epidemiol 2007;22:389-395. (Pubitemid 47052081)
18. Honein MA, Rasmussen SA, Reefhuis J, Romitti PA, Lammer EJ, Sun L, Correa A. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 2007; 18226-18233.
19. Itikala PR, Watkins ML, Mulinare J, Moore CA, Liu Y. Maternal multivitamin use and orofacial clefts in offspring. Teratology 2001; 63:79-86.
20. Kallén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy.3. Congenital malformations in the enfants. Eur J Clin Pharmacol 2007;63:383-388. (Pubitemid 46399130)
21. Kallén B, Rydhstroem H, Aberg A. Asthma during pregnancy-a population based study. Eur J Epidemiol 2000;16:167-171. (Pubitemid 30322123)
22. Khoury MJ, Erickson JD, James LM. Maternal factors in cleft lip with or without palate: evidence from interracial crosses in the United States. Teratology 1983;27:351-357. (Pubitemid 13072618)
23. Kwon HL, Triche EW, Belanger K, Bracken MB. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006;26:29-62. (Pubitemid 43144610)
24. Leite IC, Koifman S. Oral clefts, consanguinity, parental tobacco and alcohol use: a case-control study in Rio de Janeiro, Brazil. Braz Oral Res 2009;23:31-37.
25. Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C. Maternal asthma, asthma medication use, and the risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol 2009;85:161-168.
26. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: mechanisms and treatment. Eur Respir J 2005;25:731-750.
27. NAEEP Expert Panel Report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005;115:34-46.
28. Nandakumaran M, Gardey CL, Challier JC, Richard MO, Panigel M, Olive G. Transfer of Salbutamol in the human placenta in vitro. Dev Pharmacol Ther 1981;3:88-98. (Pubitemid 11027924)
29. Omarini D, Barzago MM, Bortolotti A, Lucchini G, Stellari F, Efrati F, Bonati M. Placental transfer of theophylline in an in vitro closed perfusion system of human placenta isolated lobule. Eur J Drug Metab Pharmacokinet 1993;18:369-374. (Pubitemid 24099783)
30. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D et al. Birth defects after maternal exposure to corticosteroid : prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-392.
31. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, National birth defects prevention study. Guideines for case classification for the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol 2003;67:193-201. (Pubitemid 37238061)
32. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT, EuroMAP Group. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 2001;12:461-466. (Pubitemid 32566489)
33. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998;58: 2-5. (Pubitemid 28404243)
34. Romitti PA, Sun L, Honein MA, Reefhuis J, Correa A, Rasmussen SA. Maternal periconceptional alcohol consumption and the risk of oral clefts. Am J Epidemiol 2007;166:775-785. (Pubitemid 47428900)
35. Shi M, Christensen K, Weinberg CR, Romitti P, Bathum L, Lozoda A, Morris RW, Lovett M, Murray JC. Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 2007;80:76-90. (Pubitemid 46047652)
36. Shibata M, Wachi M, Kawaguchi M, Kojima J, Onodera K. Teratogenic and fetal toxicity following intravenous theophilline administration in pregnant rabbits is related to maternal drug plasma levels. Method Find Exp Clin Pharmacol 2000;22:101-107. (Pubitemid 30304437)
37. Sodha RJ, Schneider H. Transplacental transfer of beta-adrenergic drugs studied by an in vitro perfusion method of an isolated human placental lobule. Am J Obstet Gynecol 1983;147:303-310. (Pubitemid 13015808)
38. Sull JW, Liang KY, Hetmanski JB, Wu T, Fallin MD, Ingersoll RG, Park JW, Wu-Chou YH, Chen PK, Chong SS et al. Evidence that TGFA influences risk to cleft lip with/without cleft palate through unconventional genetic mechanisms. Birth Defects Res A Clin Mol Teratol 2010;88:84-93.
39. Szabo KT, Diffebo ME, Kang YJ. Effects of several beta-receptor agonists on fetal development in various species of laboratory animals: preliminary report (abstract). Teratology 1975;12:336-337.
40. Tamasi L, Somoskovi A, Muller V, Bartfai Z, Acs N, Puho E, Czeizel AE. A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities in the offspring. J Asthma 2006;43:81-86.
41. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989; 129:415-421. (Pubitemid 19047007)
42. Wilton LV, Peace GL, Martin RM, Mackay FJ, Mann RD. The outcome of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998;105:882-889. (Pubitemid 28423505)
43. Yoon PW, Rasmussan SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA et al. The National birth defects prevention study. Public Health Rep 2001; 116 (Suppl1):32-40. (Pubitemid 32822091)
44. Zucchero TM, Cooper ME, Maher BS, Daack-Hirsch S, Nepomuceno B, Ribeiro L, Caprau D, Christensen K, Suzuki Y, Machida J et al. Interferon regulatory factor 6 (IRF6) genevariants and the risk of isolated cleft lip or palate. N Engl J Med 2004;351:769-780. (Pubitemid 39095312)